{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:50:02Z","timestamp":1794376202933,"version":"4.9.0"},"reference-count":130,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Liver Research"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.livres.2022.02.002","type":"journal-article","created":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T02:47:28Z","timestamp":1646275648000},"page":"10-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Portopulmonary hypertension: Current developments and future perspectives"],"prefix":"10.1016","volume":"6","author":[{"given":"Huawei","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoquan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6624-5463","authenticated-orcid":false,"given":"Renren","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8153-3754","authenticated-orcid":false,"given":"Yanjing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.livres.2022.02.002_bib1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/BF00957586","article-title":"Der Verlauf des Entz\u00fcndungsprozesses im Bindegewebe[The course of inflammation in connective tissue](Undetermined Language)","volume":"322","author":"Grawitz","year":"1952","journal-title":"Virchows Arch Pathol Anat Physiol Klin Med"},{"key":"10.1016\/j.livres.2022.02.002_bib2","first-page":"849","article-title":"Pulmonary hypertension complicating portal hypertension","volume":"120","author":"Lebrec","year":"1979","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.livres.2022.02.002_bib3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1053\/jhep.2003.50060","article-title":"Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study","volume":"37","author":"Colle","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2022.02.002_bib4","doi-asserted-by":"crossref","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.livres.2022.02.002_bib5","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.cld.2014.01.004","article-title":"Portopulmonary hypertension","volume":"18","author":"Cartin-Ceba","year":"2014","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.livres.2022.02.002_bib6","doi-asserted-by":"crossref","first-page":"40S","DOI":"10.1016\/j.jacc.2004.02.032","article-title":"Diagnosis and differential assessment of pulmonary arterial hypertension","volume":"43","author":"Barst","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.livres.2022.02.002_bib7","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1016\/j.jacc.2004.02.037","article-title":"Clinical classification of pulmonary hypertension","volume":"43","author":"Simonneau","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.livres.2022.02.002_bib8","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.healun.2016.12.014","article-title":"Survival in portopulmonary hypertension: outcomes of the United Kingdom national pulmonary arterial hypertension registry","volume":"36","author":"Sithamparanathan","year":"2017","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.livres.2022.02.002_bib9","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.ijcard.2015.11.001","article-title":"Incidence and prevalence of pulmonary arterial hypertension in Germany","volume":"203","author":"Hoeper","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.livres.2022.02.002_bib10","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1164\/rccm.200804-613OC","article-title":"Portopulmonary hypertension: survival and prognostic factors","volume":"178","author":"Le Pavec","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.livres.2022.02.002_bib11","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1183\/09031936.00101211","article-title":"Survival in pulmonary hypertension in Spain: insights from the Spanish registry","volume":"40","author":"Escribano-Subias","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.livres.2022.02.002_bib12","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jhep.2020.02.021","article-title":"Portopulmonary hypertension in the current era of pulmonary hypertension management","volume":"73","author":"Savale","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2022.02.002_bib13","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/imj.14751","article-title":"Portopulmonary hypertension: prognosis and management in the current treatment era - results from the REHAP registry","volume":"51","author":"Lazaro Salvador","year":"2021","journal-title":"Intern Med J"},{"key":"10.1016\/j.livres.2022.02.002_bib14","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1111\/j.1600-6143.2008.02384.x","article-title":"Survival in portopulmonary hypertension: Mayo Clinic experience categorized by treatment subgroups","volume":"8","author":"Swanson","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.livres.2022.02.002_bib15","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1097\/TP.0000000000001229","article-title":"International liver transplant society practice guidelines: diagnosis and management of hepatopulmonary syndrome and portopulmonary hypertension","volume":"100","author":"Krowka","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.livres.2022.02.002_bib16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41569-020-0433-5","article-title":"Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complications","volume":"18","author":"Matyas","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.livres.2022.02.002_bib17","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1111\/j.1572-0241.2001.04668.x","article-title":"Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis","volume":"96","author":"Bauer","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.livres.2022.02.002_bib18","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/S0168-8278(97)80474-6","article-title":"Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites","volume":"26","author":"Guarner","year":"1997","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2022.02.002_bib19","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/MPG.0000000000000821","article-title":"Portopulmonary hypertension in liver disease presenting in childhood","volume":"61","author":"Ecochard-Dugelay","year":"2015","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.livres.2022.02.002_bib20","doi-asserted-by":"crossref","first-page":"H2210","DOI":"10.1152\/ajpheart.00688.2007","article-title":"CB2-receptor stimulation attenuates TNF-alpha-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion","volume":"293","author":"Rajesh","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.livres.2022.02.002_bib21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/bs.ircmb.2016.05.001","article-title":"Mutually supportive mechanisms of inflammation and vascular remodeling","volume":"326","author":"Whiteford","year":"2016","journal-title":"Int Rev Cell Mol Biol"},{"key":"10.1016\/j.livres.2022.02.002_bib22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1152\/physrev.00029.2006","article-title":"Nitric oxide and peroxynitrite in health and disease","volume":"87","author":"Pacher","year":"2007","journal-title":"Physiol Rev"},{"key":"10.1016\/j.livres.2022.02.002_bib23","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1080\/00365520510024278","article-title":"Intestinal permeability in cirrhotic patients with and without ascites","volume":"41","author":"Kalaitzakis","year":"2006","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.livres.2022.02.002_bib24","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/ajg.2009.558","article-title":"Intestinal permeability in cirrhotic patients with and without spontaneous bacterial peritonitis: is the ring closed?","volume":"105","author":"Scarpellini","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.livres.2022.02.002_bib25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/liv.12562","article-title":"Characteristic haemodynamic changes of cirrhosis may influence the diagnosis of portopulmonary hypertension","volume":"35","author":"Chiva","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.livres.2022.02.002_bib26","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1183\/09031936.98.11051153","article-title":"Pulmonary vascular disorders in portal hypertension","volume":"11","author":"Herv\u00e9","year":"1998","journal-title":"Eur Respir J"},{"key":"10.1016\/j.livres.2022.02.002_bib27","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0168-8278(97)80173-0","article-title":"Continuous blood pressure monitoring in cirrhosis. Relations to splanchnic and systemic haemodynamics","volume":"27","author":"M\u00f8ller","year":"1997","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2022.02.002_bib28","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/gut.52.9.1355","article-title":"Portopulmonary hypertension in decompensated cirrhosis with refractory ascites","volume":"52","author":"Benjaminov","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.livres.2022.02.002_bib29","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1053\/he.2000.6596","article-title":"Production and release of endothelin-1 from the gut and spleen in portal hypertension due to cirrhosis","volume":"31","author":"Nagasue","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2022.02.002_bib30","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1378\/chest.115.6.1708","article-title":"Alpha1-adrenergic hypothesis for pulmonary hypertension","volume":"115","author":"Salvi","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.livres.2022.02.002_bib31","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1111\/liv.12791","article-title":"Hepatopulmonary syndrome and portopulmonary hypertension: recent knowledge in pathogenesis and overview of clinical assessment","volume":"35","author":"Raevens","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.livres.2022.02.002_bib32","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.clinre.2014.12.011","article-title":"Porto-pulmonary hypertension: a comprehensive review","volume":"39","author":"Liberal","year":"2015","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.livres.2022.02.002_bib33","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1164\/rccm.200301-147OC","article-title":"Oxidative stress in severe pulmonary hypertension","volume":"169","author":"Bowers","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.livres.2022.02.002_bib34","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/hep.31314","article-title":"Estrogen signaling and portopulmonary hypertension: the pulmonary vascular complications of liver disease study (PVCLD2)","volume":"73","author":"Al-Naamani","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2022.02.002_bib35","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1164\/rccm.200809-1472OC","article-title":"Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease","volume":"179","author":"Roberts","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.livres.2022.02.002_bib36","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/hep.26664","article-title":"The role of macrophage migration inhibitory factor in autoimmune liver disease","volume":"59","author":"Assis","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2022.02.002_bib37","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1086\/688489","article-title":"Macrophage migration inhibitory factor as a novel biomarker of portopulmonary hypertension","volume":"6","author":"DuBrock","year":"2016","journal-title":"Pulm Circ"},{"key":"10.1016\/j.livres.2022.02.002_bib38","doi-asserted-by":"crossref","first-page":"17937","DOI":"10.1074\/jbc.275.24.17937","article-title":"Bone morphogenetic protein-9. An autocrine\/paracrine cytokine in the liver","volume":"275","author":"Miller","year":"2000","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.livres.2022.02.002_bib39","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1164\/rccm.201807-1236OC","article-title":"Bone morphogenetic protein 9 is a mechanistic biomarker of portopulmonary hypertension","volume":"199","author":"Nikolic","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.livres.2022.02.002_bib40","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1164\/rccm.201912-2514LE","article-title":"BMP9\/10 in pulmonary vascular complications of liver disease","volume":"201","author":"Rochon","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.livres.2022.02.002_bib41","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1164\/rccm.202005-1761OC","article-title":"Circulating BMP9 protects the pulmonary endothelium during inflammation-induced lung injury in mice","volume":"203","author":"Li","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.livres.2022.02.002_bib42","doi-asserted-by":"crossref","DOI":"10.1177\/2045894020962917","article-title":"Burden of pulmonary hypertension in patients with portal hypertension in the United States: a retrospective database study","volume":"10","author":"Sahay","year":"2020","journal-title":"Pulm Circ"},{"key":"10.1016\/j.livres.2022.02.002_bib43","doi-asserted-by":"crossref","first-page":"5595614","DOI":"10.1155\/2021\/5595614","article-title":"Prevalence and associated factors of portopulmonary hypertension in patients with portal hypertension: a case-control study","volume":"2021","author":"Shao","year":"2021","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.livres.2022.02.002_bib44","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s12072-008-9080-3","article-title":"Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update","volume":"2","author":"Liaw","year":"2008","journal-title":"Hepatol Int"},{"key":"10.1016\/j.livres.2022.02.002_bib45","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2022.02.002_bib46","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1164\/rccm.200510-1668OC","article-title":"Pulmonary arterial hypertension in France: results from a national registry","volume":"173","author":"Humbert","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.livres.2022.02.002_bib47","doi-asserted-by":"crossref","first-page":"6836973","DOI":"10.1155\/2020\/6836973","article-title":"Clinical and instrumental characteristics of newly diagnosed patients with various forms of pulmonary hypertension according to the Russian National Registry","volume":"2020","author":"Chazova","year":"2020","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.livres.2022.02.002_bib48","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1378\/chest.09-1140","article-title":"Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry","volume":"137","author":"Badesch","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.livres.2022.02.002_bib49","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/0016-5085(91)90225-A","article-title":"Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics","volume":"100","author":"Hadengue","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2022.02.002_bib50","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/hep.21431","article-title":"Portopulmonary hypertension: results from a 10-year screening algorithm","volume":"44","author":"Krowka","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2022.02.002_bib51","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0016-5085(03)00969-7","article-title":"Portopulmonary hypertension: an increasingly important complication of cirrhosis","volume":"125","author":"Blendis","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2022.02.002_bib52","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/CRD.0000000000000195","article-title":"Diagnosis, treatment, and management of orthotopic liver transplant candidates with portopulmonary hypertension","volume":"26","author":"Koulava","year":"2018","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.livres.2022.02.002_bib53","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/hepr.13560","article-title":"Prevalence and characteristics of portopulmonary hypertension in cirrhotic patients who underwent both hepatic vein and pulmonary artery catheterization","volume":"50","author":"Atsukawa","year":"2020","journal-title":"Hepatol Res"},{"key":"10.1016\/j.livres.2022.02.002_bib54","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/hep.22275","article-title":"Clinical risk factors for portopulmonary hypertension","volume":"48","author":"Kawut","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2022.02.002_bib55","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/lt.23649","article-title":"Echocardiography for the detection of portopulmonary hypertension in liver transplant candidates: an analysis of cutoff values","volume":"19","author":"Raevens","year":"2013","journal-title":"Liver Transpl"},{"key":"10.1016\/j.livres.2022.02.002_bib56","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/jlts.2000.6356","article-title":"Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation","volume":"6","author":"Krowka","year":"2000","journal-title":"Liver Transpl"},{"key":"10.1016\/j.livres.2022.02.002_bib57","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1097\/TP.0000000000001666","article-title":"Predictors of waitlist mortality in portopulmonary hypertension","volume":"101","author":"DuBrock","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.livres.2022.02.002_bib58","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.chest.2020.07.081","article-title":"Sex differences in portopulmonary hypertension","volume":"159","author":"DuBrock","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.livres.2022.02.002_bib59","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1053\/j.gastro.2018.01.028","article-title":"Association between portosystemic shunts and increased complications and mortality in patients with cirrhosis","volume":"154","author":"Sim\u00f3n-Talero","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2022.02.002_bib60","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1053\/j.gastro.2011.06.053","article-title":"Prevalence of spontaneous portosystemic shunts in patients with portopulmonary hypertension and effect on treatment","volume":"141","author":"Talwalkar","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2022.02.002_bib61","doi-asserted-by":"crossref","DOI":"10.1177\/2045894019895426","article-title":"Association between splenectomy and portal hypertension in the development of pulmonary hypertension","volume":"10","author":"Huang","year":"2020","journal-title":"Pulm Circ"},{"key":"10.1016\/j.livres.2022.02.002_bib62","doi-asserted-by":"crossref","first-page":"E340","DOI":"10.1111\/hepr.12930","article-title":"Relationship between portopulmonary hypertension and splenectomy: Mayo Clinic experience and review of published works","volume":"48","author":"Segraves","year":"2018","journal-title":"Hepatol Res"},{"key":"10.1016\/j.livres.2022.02.002_bib63","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/bjs.7002","article-title":"Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertension","volume":"97","author":"Kinjo","year":"2010","journal-title":"Br J Surg"},{"key":"10.1016\/j.livres.2022.02.002_bib64","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3892\/etm.2013.918","article-title":"Portopulmonary hypertension in cirrhotic patients: prevalence, clinical features and risk factors","volume":"5","author":"Chen","year":"2013","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.livres.2022.02.002_bib65","first-page":"9629570","article-title":"Prevalence and prognosis of portopulmonary hypertension in 223 liver transplant recipients","volume":"2018","author":"Li","year":"2018","journal-title":"Can Respir J"},{"key":"10.1016\/j.livres.2022.02.002_bib66","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0735-1097(10)80121-4","article-title":"Association between primary pulmonary hypertension and portal hypertension: analysis of its pathophysiology and clinical, laboratory and hemodynamic manifestations","volume":"17","author":"Robalino","year":"1991","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.livres.2022.02.002_bib67","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/ACO.0b013e32833725c4","article-title":"Portopulmonary hypertension and right heart failure in patients with cirrhosis","volume":"23","author":"Ramsay","year":"2010","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1016\/j.livres.2022.02.002_bib68","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1183\/09059180.00007211","article-title":"Portopulmonary hypertension and hepatopulmonary syndrome: a clinician-oriented overview","volume":"21","author":"Porres-Aguilar","year":"2012","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.livres.2022.02.002_bib69","doi-asserted-by":"crossref","first-page":"85S","DOI":"10.1378\/chest.09-2816","article-title":"Worldwide physician education and training in pulmonary hypertension: pulmonary vascular disease: the global perspective","volume":"137","author":"Elliott","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.livres.2022.02.002_bib70","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0735-1097(87)80123-7","article-title":"Coexistent pulmonary and portal hypertension: morphologic and clinical features","volume":"10","author":"Edwards","year":"1987","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.livres.2022.02.002_bib71","doi-asserted-by":"crossref","first-page":"909","DOI":"10.2214\/ajr.151.5.909","article-title":"Pulmonary hypertension complicating portal hypertension: findings on chest radiographs","volume":"151","author":"Chan","year":"1988","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.livres.2022.02.002_bib72","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1378\/chest.121.6.1869","article-title":"Arterial oxygenation associated with portopulmonary hypertension","volume":"121","author":"Swanson","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.livres.2022.02.002_bib73","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13995","article-title":"Performance of echocardiography for detection of portopulmonary hypertension among liver transplant candidates: meta-analysis","volume":"34","author":"Korbitz","year":"2020","journal-title":"Clin Transplant"},{"key":"10.1016\/j.livres.2022.02.002_bib74","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1053\/jlts.2002.35554","article-title":"Role of echocardiography in detecting portopulmonary hypertension in liver transplant candidates","volume":"8","author":"Cotton","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1016\/j.livres.2022.02.002_bib75","doi-asserted-by":"crossref","first-page":"e256","DOI":"10.1097\/MD.0000000000000256","article-title":"CT-base pulmonary artery measurement in the detection of pulmonary hypertension: a meta-analysis and systematic review","volume":"93","author":"Shen","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.livres.2022.02.002_bib76","article-title":"Screening for portopulmonary hypertension using computed tomography-based measurements of the main pulmonary artery and ascending aorta diameters in patients with portal hypertension","volume":"10.1111\/hepr.13735","author":"Ishikawa","year":"2021","journal-title":"Hepatol Res"},{"key":"10.1016\/j.livres.2022.02.002_bib77","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1532-429X-14-6","article-title":"Cardiovascular magnetic resonance in pulmonary hypertension","volume":"14","author":"Bradlow","year":"2012","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.livres.2022.02.002_bib78","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.diii.2019.12.008","article-title":"Quantification of right ventricular extracellular volume in pulmonary hypertension using cardiac magnetic resonance imaging","volume":"101","author":"Habert","year":"2020","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.livres.2022.02.002_bib79","doi-asserted-by":"crossref","first-page":"108784","DOI":"10.1016\/j.ejrad.2019.108784","article-title":"Cardiac magnetic resonance imaging as a prognostic biomarker in treatment- na\u00efve pulmonary hypertension","volume":"123","author":"Jose","year":"2020","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.livres.2022.02.002_bib80","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s10554-018-1448-4","article-title":"Advanced imaging in pulmonary hypertension: emerging techniques and applications","volume":"35","author":"Rengier","year":"2019","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.livres.2022.02.002_bib81","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/TP.0000000000001517","article-title":"Frequency and outcomes of patients with increased mean pulmonary artery pressure at the time of liver transplantation","volume":"101","author":"DeMartino","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.livres.2022.02.002_bib82","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ejim.2011.02.018","article-title":"Portopulmonary hypertension: from diagnosis to treatment","volume":"22","author":"Giusca","year":"2011","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.livres.2022.02.002_bib83","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1097\/TP.0000000000003490","article-title":"Clinical outcomes after liver transplantation in patients with portopulmonary hypertension","volume":"105","author":"Cartin-Ceba","year":"2021","journal-title":"Transplantation"},{"key":"10.1016\/j.livres.2022.02.002_bib84","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.recesp.2016.01.002","article-title":"2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"69","author":"Gali\u00e8","year":"2016","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.livres.2022.02.002_bib85","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.gastro.2005.10.013","article-title":"Deleterious effects of beta-blockers on exercise capacity and hemodynamics in patients with portopulmonary hypertension","volume":"130","author":"Provencher","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2022.02.002_bib86","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1093\/eurheartj\/ehq170","article-title":"Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension","volume":"31","author":"Montani","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.livres.2022.02.002_bib87","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/hep.510230507","article-title":"Pulmonary hypertension after transjugular intrahepatic portosystemic shunt: effects on right ventricular function","volume":"23","author":"Van der Linden","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2022.02.002_bib88","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/j.1600-6143.2006.01701.x","article-title":"The impact of treatment of portopulmonary hypertension on survival following liver transplantation","volume":"7","author":"Ashfaq","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.livres.2022.02.002_bib89","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1378\/chest.10-0574","article-title":"Safety and efficacy of ambrisentan for the treatment of portopulmonary hypertension","volume":"139","author":"Cartin-Ceba","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.livres.2022.02.002_bib90","first-page":"77","article-title":"Hepatotoxicity by bosentan in a patient with portopulmonary hypertension\u202f: a case-report and review of the literature","volume":"20","author":"Eriksson","year":"2011","journal-title":"J\u00a0Gastrointestin Liver Dis"},{"key":"10.1016\/j.livres.2022.02.002_bib91","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/lt.21174","article-title":"Long-term follow-up of portopulmonary hypertension: effect of treatment with epoprostenol","volume":"13","author":"Fix","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.livres.2022.02.002_bib92","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/MEG.0b013e32835c504b","article-title":"Oral vasodilator therapy in patients with moderate to severe portopulmonary hypertension as a bridge to liver transplantation","volume":"25","author":"Raevens","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2022.02.002_bib93","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/hep.31164","article-title":"Vasomodulators and liver transplantation for portopulmonary hypertension: evidence from a systematic review and meta-analysis","volume":"72","author":"Deroo","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2022.02.002_bib94","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.dld.2016.10.010","article-title":"Oral pulmonary vasoactive drugs achieve hemodynamic eligibility for liver transplantation in portopulmonary hypertension","volume":"49","author":"Legros","year":"2017","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.livres.2022.02.002_bib95","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/hep.510300307","article-title":"Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): a study of 15 patients with moderate to severe portopulmonary hypertension","volume":"30","author":"Krowka","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2022.02.002_bib96","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1432-2277.2008.00830.x","article-title":"Initial experience using continuous intravenous treprostinil to manage pulmonary arterial hypertension in patients with end-stage liver disease","volume":"22","author":"Sakai","year":"2009","journal-title":"Transpl Int"},{"key":"10.1016\/j.livres.2022.02.002_bib97","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1183\/09031936.00032407","article-title":"Experience with inhaled iloprost and bosentan in portopulmonary hypertension","volume":"30","author":"Hoeper","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.livres.2022.02.002_bib98","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/lt.21997","article-title":"Acute and long-term effects of inhaled iloprost in portopulmonary hypertension","volume":"16","author":"Melgosa","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1016\/j.livres.2022.02.002_bib99","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/lt.500050517","article-title":"Progressive splenomegaly after epoprostenol therapy in portopulmonary hypertension","volume":"5","author":"Findlay","year":"1999","journal-title":"Liver Transpl Surg"},{"key":"10.1016\/j.livres.2022.02.002_bib100","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s001340050044","article-title":"Inhaled prostacyclin and platelet function after cardiac surgery and cardiopulmonary bypass","volume":"26","author":"Haraldsson","year":"2000","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.livres.2022.02.002_bib101","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MAJ.0b013e31824184b1","article-title":"Epoprostenol-induced hypersplenism in portopulmonary hypertension","volume":"344","author":"Touma","year":"2012","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.livres.2022.02.002_bib102","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Gali\u00e8","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.livres.2022.02.002_bib103","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/lt.21479","article-title":"Sildenafil monotherapy in portopulmonary hypertension can facilitate liver transplantation","volume":"15","author":"Hemnes","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.livres.2022.02.002_bib104","first-page":"42","article-title":"Effectiveness of phosphodiesterase-5 inhibitor therapy for portopulmonary hypertension","volume":"22","author":"Fisher","year":"2015","journal-title":"Can Respir J"},{"key":"10.1016\/j.livres.2022.02.002_bib105","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1183\/09031936.06.00030206","article-title":"Sildenafil treatment for portopulmonary hypertension","volume":"28","author":"Reichenberger","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.livres.2022.02.002_bib106","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1183\/09031936.05.00080804","article-title":"Bosentan therapy for portopulmonary hypertension","volume":"25","author":"Hoeper","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.livres.2022.02.002_bib107","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1183\/09031936.00117511","article-title":"Efficacy, safety and pharmacokinetics of bosentan in portopulmonary hypertension","volume":"41","author":"Savale","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.livres.2022.02.002_bib108","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S2213-2600(19)30091-8","article-title":"Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial","volume":"7","author":"Sitbon","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.livres.2022.02.002_bib109","first-page":"1258","article-title":"Ambrisentan improves exercise capacity and symptoms in patients with portopulmonary hypertension","volume":"49","author":"Halank","year":"2011","journal-title":"Z\u00a0Gastroenterol"},{"key":"10.1016\/j.livres.2022.02.002_bib110","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.healun.2019.12.008","article-title":"Ambrisentan in portopulmonary hypertension: a multicenter, open-label trial","volume":"39","author":"Preston","year":"2020","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.livres.2022.02.002_bib111","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","article-title":"Riociguat for the treatment of pulmonary arterial hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.livres.2022.02.002_bib112","doi-asserted-by":"crossref","DOI":"10.1177\/2045894018769305","article-title":"Riociguat treatment for portopulmonary hypertension: a subgroup analysis from the PATENT-1\/-2 studies","volume":"8","author":"Cartin-Ceba","year":"2018","journal-title":"Pulm Circ"},{"key":"10.1016\/j.livres.2022.02.002_bib113","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S2213-2600(20)30532-4","article-title":"Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial","volume":"9","author":"Hoeper","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.livres.2022.02.002_bib114","doi-asserted-by":"crossref","first-page":"521","DOI":"10.7326\/0003-4819-149-8-200810210-00004","article-title":"Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial","volume":"149","author":"Simonneau","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.livres.2022.02.002_bib115","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1056\/NEJMoa1413687","article-title":"Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension","volume":"373","author":"Gali\u00e8","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.livres.2022.02.002_bib116","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1164\/rccm.200603-358OC","article-title":"Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension","volume":"174","author":"McLaughlin","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.livres.2022.02.002_bib117","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1183\/09031936.00116313","article-title":"Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study","volume":"43","author":"Sitbon","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.livres.2022.02.002_bib118","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.healun.2011.11.002","article-title":"Usefulness of first-line combination therapy with epoprostenol and bosentan in pulmonary arterial hypertension: an observational study","volume":"31","author":"Kemp","year":"2012","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.livres.2022.02.002_bib119","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1183\/13993003.02043-2015","article-title":"Initial dual oral combination therapy in pulmonary arterial hypertension","volume":"47","author":"Sitbon","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.livres.2022.02.002_bib120","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/lt.21310","article-title":"Safety and efficacy of combined use of sildenafil, bosentan, and iloprost before and after liver transplantation in severe portopulmonary hypertension","volume":"14","author":"Austin","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.livres.2022.02.002_bib121","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1097\/TP.0000000000002142","article-title":"Management of severe portopulmonary hypertension with dual oral therapy before liver transplantation","volume":"102","author":"Vionnet","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.livres.2022.02.002_bib122","doi-asserted-by":"crossref","first-page":"1802148","DOI":"10.1183\/13993003.02148-2018","article-title":"An overview of the 6th world Symposium on pulmonary hypertension","volume":"53","author":"Gali\u00e8","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.livres.2022.02.002_bib123","first-page":"861","article-title":"ERS Task Force pulmonary-hepatic vascular disorders (PHD) scientific committee. Pulmonary-hepatic vascular disorders (PHD)","volume":"24","author":"Rodr\u00edguez -Roisin","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.livres.2022.02.002_bib124","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/hep.26972","article-title":"Evaluation for liver transplantation in adults: 2013 practice guideline by the American association for the study of liver diseases and the American society of transplantation","volume":"59","author":"Martin","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2022.02.002_bib125","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/lt.23870","article-title":"Long-term follow-up of portopulmonary hypertension patients after liver transplantation","volume":"20","author":"Khaderi","year":"2014","journal-title":"Liver Transpl"},{"key":"10.1016\/j.livres.2022.02.002_bib126","article-title":"Causes and circumstances of death in portopulmonary hypertension","volume":"7","author":"Sahay","year":"2021","journal-title":"Transplant Direct"},{"key":"10.1016\/j.livres.2022.02.002_bib127","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1002\/hep.28990","article-title":"Long-term outcome in liver transplantation candidates with portopulmonary hypertension","volume":"65","author":"Savale","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2022.02.002_bib128","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/lt.26091","article-title":"Pulmonary vascular resistance predicts mortality and graft failure in transplantation patients with portopulmonary hypertension","volume":"27","author":"Jose","year":"2021","journal-title":"Liver Transpl"},{"key":"10.1016\/j.livres.2022.02.002_bib129","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1007\/s10620-014-3065-y","article-title":"Outcomes of liver transplantation for porto-pulmonary hypertension in model for end-stage liver disease era","volume":"59","author":"Salgia","year":"2014","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.livres.2022.02.002_bib130","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1002\/lt.20979","volume":"12","author":"Freeman","year":"2006","journal-title":"Liver Transpl"}],"container-title":["Liver Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568422000058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568422000058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T14:45:45Z","timestamp":1762872345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542568422000058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":130,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S2542568422000058"],"URL":"https:\/\/doi.org\/10.1016\/j.livres.2022.02.002","relation":{},"ISSN":["2542-5684"],"issn-type":[{"value":"2542-5684","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Portopulmonary hypertension: Current developments and future perspectives","name":"articletitle","label":"Article Title"},{"value":"Liver Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.livres.2022.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Third Affiliated Hospital of Sun Yat-sen University. Publishing services by Elsevier B. V. on behalf of KeAi Communications Co., Ltd.","name":"copyright","label":"Copyright"}]}}